144 related articles for article (PubMed ID: 38123045)
1. Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trial.
Kim M; Ahn JM; Kang DY; Kim MJ; Kim KW; Koo HJ; Yang DH; Jung SC; Kim B; Wong YTA; Lam CCS; Yin WH; Wei J; Lee YT; Kao HL; Lin MS; Yu Ko T; Kim WJ; Kang SH; Lee SA; Ko E; Kim DH; Kang JW; Lee JH; Lee J; Park J; Kim H; Choi Y; Park SJ; Park DW
Am Heart J; 2024 Mar; 269():167-178. PubMed ID: 38123045
[TBL] [Abstract][Full Text] [Related]
2. Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR: The ADAPT-TAVR Randomized Clinical Trial.
Park DW; Ahn JM; Kang DY; Kim KW; Koo HJ; Yang DH; Jung SC; Kim B; Wong YTA; Lam CCS; Yin WH; Wei J; Lee YT; Kao HL; Lin MS; Ko TY; Kim WJ; Kang SH; Yun SC; Lee SA; Ko E; Park H; Kim DH; Kang JW; Lee JH; Park SJ;
Circulation; 2022 Aug; 146(6):466-479. PubMed ID: 35373583
[TBL] [Abstract][Full Text] [Related]
3. Effect of Edoxaban Versus Antiplatelet Therapy on Leaflet Thrombosis and Cerebral Thromboembolism After TAVI According to Major Clinical and Anatomic Factors in Prespecified Subgroup Analysis from the ADAPT-TAVR Trial.
Lee JH; Ahn JM; Kang DY; Kim KW; Koo HJ; Yang DH; Jung SC; Kim B; Wong YTA; Lam CCS; Yin WH; Wei J; Lee YT; Kao HL; Lin MS; Ko TY; Kim WJ; Kang SH; Yun SC; Ko E; Park H; Lee SA; Kim DH; Park SJ; Park DW;
Am J Cardiol; 2023 Sep; 203():352-361. PubMed ID: 37517131
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement.
Park H; Kang DY; Ahn JM; Kim KW; Wong AYT; Lam SCC; Yin WH; Wei J; Lee YT; Kao HL; Lin MS; Ko TY; Kim WJ; Kang SH; Ko E; Kim DH; Koo HJ; Yang DH; Kang JW; Jung SC; Lee JH; Yun SC; Park SJ; Park DW
BMJ Open; 2021 Jan; 11(1):e042587. PubMed ID: 33402409
[TBL] [Abstract][Full Text] [Related]
5. Frequency, Predictors, and Clinical Impact of Valvular and Perivalvular Thrombus After Transcatheter Aortic Valve Replacement.
Choi Y; Ahn JM; Kang DY; Kim HJ; Kim H; Lee J; Kim M; Park J; Kim KW; Koo HJ; Yang DH; Jung SC; Kim B; Anthony Wong YT; Simon Lam CC; Yin WH; Wei J; Lee YT; Kao HL; Lin MS; Ko TY; Kim WJ; Kang SH; Lee SA; Kim DH; Lee JH; Park SJ; Park DW;
JACC Cardiovasc Interv; 2023 Dec; 16(24):2967-2981. PubMed ID: 38151311
[TBL] [Abstract][Full Text] [Related]
6. Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacement.
Jang MH; Ahn JM; Kang DY; Kim KW; Koo HJ; Yang DH; Jung SC; Kim B; Wong YTA; Lam CCS; Yin WH; Wei J; Lee YT; Kao HL; Lin MS; Ko TY; Kim WJ; Kang SH; Ko E; Lee SA; Kim DH; Kim H; Choi Y; Lee J; Park SJ; Park DW
Heart; 2023 Dec; 110(2):140-147. PubMed ID: 37586823
[TBL] [Abstract][Full Text] [Related]
7. Challenges in Aortic Stenosis: Review of Antiplatelet/Anticoagulant Therapy Management with Transcatheter Aortic Valve Replacement (TAVR): TAVR with Recent PCI, TAVR in the Patient with Atrial Fibrillation, and TAVR Thrombosis Management.
Sherwood MW; Vora AN
Curr Cardiol Rep; 2018 Oct; 20(12):130. PubMed ID: 30311013
[TBL] [Abstract][Full Text] [Related]
8. Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial.
Van Mieghem NM; Unverdorben M; Valgimigli M; Mehran R; Boersma E; Baber U; Hengstenberg C; Shi M; Chen C; Saito S; Veltkamp R; Vranckx P; Dangas GD
Am Heart J; 2018 Nov; 205():63-69. PubMed ID: 30172099
[TBL] [Abstract][Full Text] [Related]
9. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study.
Chakravarty T; Søndergaard L; Friedman J; De Backer O; Berman D; Kofoed KF; Jilaihawi H; Shiota T; Abramowitz Y; Jørgensen TH; Rami T; Israr S; Fontana G; de Knegt M; Fuchs A; Lyden P; Trento A; Bhatt DL; Leon MB; Makkar RR; ;
Lancet; 2017 Jun; 389(10087):2383-2392. PubMed ID: 28330690
[TBL] [Abstract][Full Text] [Related]
10. Apixaban and Valve Thrombosis After Transcatheter Aortic Valve Replacement: The ATLANTIS-4D-CT Randomized Clinical Trial Substudy.
Montalescot G; Redheuil A; Vincent F; Desch S; De Benedictis M; Eltchaninoff H; Trenk D; Serfaty JM; Charpentier E; Bouazizi K; Prigent M; Guedeney P; Salloum T; Berti S; Cequier A; Lefèvre T; Leprince P; Silvain J; Van Belle E; Neumann FJ; Portal JJ; Vicaut E; Collet JP;
JACC Cardiovasc Interv; 2022 Sep; 15(18):1794-1804. PubMed ID: 36137682
[TBL] [Abstract][Full Text] [Related]
11. Leaflet Thickening and Motion After Transcatheter Aortic Valve Replacement: Design and Rationale of the Rotterdam Edoxaban Trial.
van Wiechen MP; El Azzouzi I; Knol WG; Adrichem R; Hokken TW; Ooms JF; de Ronde-Tillmans MJ; Daemen J; de Jaegere PP; Hirsch A; Budde RPJ; Van Mieghem NM
Cardiovasc Revasc Med; 2022 Nov; 44():67-70. PubMed ID: 35787831
[TBL] [Abstract][Full Text] [Related]
12. Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement: A Meta-Analysis.
Bogyi M; Schernthaner RE; Loewe C; Gager GM; Dizdarevic AM; Kronberger C; Postula M; Legutko J; Velagapudi P; Hengstenberg C; Siller-Matula JM
JACC Cardiovasc Interv; 2021 Dec; 14(24):2643-2656. PubMed ID: 34949391
[TBL] [Abstract][Full Text] [Related]
13. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.
Rodés-Cabau J; Masson JB; Welsh RC; Garcia Del Blanco B; Pelletier M; Webb JG; Al-Qoofi F; Généreux P; Maluenda G; Thoenes M; Paradis JM; Chamandi C; Serra V; Dumont E; Côté M
JACC Cardiovasc Interv; 2017 Jul; 10(13):1357-1365. PubMed ID: 28527771
[TBL] [Abstract][Full Text] [Related]
14. Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Van Mieghem NM; Unverdorben M; Hengstenberg C; Möllmann H; Mehran R; López-Otero D; Nombela-Franco L; Moreno R; Nordbeck P; Thiele H; Lang I; Zamorano JL; Shawl F; Yamamoto M; Watanabe Y; Hayashida K; Hambrecht R; Meincke F; Vranckx P; Jin J; Boersma E; Rodés-Cabau J; Ohlmann P; Capranzano P; Kim HS; Pilgrim T; Anderson R; Baber U; Duggal A; Laeis P; Lanz H; Chen C; Valgimigli M; Veltkamp R; Saito S; Dangas GD;
N Engl J Med; 2021 Dec; 385(23):2150-2160. PubMed ID: 34449183
[TBL] [Abstract][Full Text] [Related]
15. Comparison of dual antiplatelet therapy versus oral anticoagulation following transcatheter aortic valve replacement: A retrospective single-center registry analysis.
Holy EW; Kebernik J; Allali A; El-Mawardy M; Richardt G; Abdel-Wahab M
Cardiol J; 2017; 24(6):649-659. PubMed ID: 28497845
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet strategy after transcatheter aortic valve replacement: an updated meta-analysis.
Ma X; Xu Z; Li J; Zhao D; Kong X; Ma J; Ma H; Yun Y; Sun L; Zhang Y; Wei D; Jiao Q; Zou C; Wang Z
J Cardiovasc Surg (Torino); 2019 Oct; 60(5):624-632. PubMed ID: 31486613
[TBL] [Abstract][Full Text] [Related]
17. Dual Versus Single Antiplatelet Regimen With or Without Anticoagulation in Transcatheter Aortic Valve Replacement: Indirect Comparison and Meta-analysis.
Verdoia M; Barbieri L; Nardin M; Suryapranata H; De Luca G
Rev Esp Cardiol (Engl Ed); 2018 Apr; 71(4):257-266. PubMed ID: 28734880
[TBL] [Abstract][Full Text] [Related]
18. Subclinical Leaflet Thrombosis Following Surgical and Transcatheter Aortic Valve Replacement: A Meta-Analysis.
Moscarelli M; Prestera R; Pernice V; Milo S; Violante F; Cuffari F; Di Pasquale C; Ferlisi A; Speziale G; Angelini GD; Fattouch K
Am J Cardiol; 2023 Oct; 204():171-177. PubMed ID: 37544140
[TBL] [Abstract][Full Text] [Related]
19. Subclinical leaflet thrombosis and antithrombotic therapy post-TAVI: An LRT substudy.
Bhogal S; Waksman R; Gordon P; Ehsan A; Wilson SR; Levitt R; Parikh P; Bilfinger T; Hanna N; Buchbinder M; Asch FM; Weissman G; Ben-Dor I; Shults CC; Ali S; Shea C; Zhang C; Garcia-Garcia HM; Satler LF; Rogers T
Int J Cardiol; 2023 Jan; 371():305-311. PubMed ID: 36272571
[TBL] [Abstract][Full Text] [Related]
20. Bioprosthetic leaflet thrombosis and reduced leaflet motion after transcatheter aortic valve replacement: A systematic review and meta-analysis.
Roule V; Guedeney P; Silvain J; Beygui F; Zeitouni M; Sorrentino S; Kerneis M; Barthelemy O; Beaupré F; Portal JJ; Vicaut E; Montalescot G; Collet JP
Arch Cardiovasc Dis; 2023 Dec; 116(12):563-571. PubMed ID: 37968182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
